Otero Jose Manuel (CIK 2024096) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy LXEO (12,060 shares), Sell LXEO (4,666 shares), Sell LXEO (1,302 shares), Buy LXEO (5,930 shares), Sell LXEO (3,016 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Lexeo Therapeutics, Inc. (LXEO) | Chief Operating Officer | Buy | 12,060 | $0 |
| 2026-07-01 | Lexeo Therapeutics, Inc. (LXEO) | Chief Operating Officer | Sell | 4,666 | $20,904 |
| 2026-05-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Operating Officer | Sell | 1,302 | $6,606 |
| 2026-03-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Operating Officer | Buy | 5,930 | $15,655 |
| 2026-02-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Operating Officer | Sell | 3,016 | $19,302 |
| 2026-02-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Operating Officer | Sell | 721 | $6,684 |
| 2026-02-06 | Lexeo Therapeutics, Inc. (LXEO) | Chief Operating Officer | Buy | 65,000 | $0 |
| 2025-11-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Technical Officer | Sell | 721 | $6,684 |
| 2025-10-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Technical Officer | Buy | 5,940 | $0 |
| 2025-10-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Technical Officer | Sell | 2,091 | $18,694 |
| 2025-10-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Technical Officer | Sell | 24 | $229 |
| 2025-08-20 | Lexeo Therapeutics, Inc. (LXEO) | Chief Technical Officer | Sell | 2,848 | $13,300 |
| 2025-04-09 | Lexeo Therapeutics, Inc. (LXEO) | Chief Technical Officer | Buy | 5,720 | $14,929 |
Source: SEC Form 4 filings · as of 2026-07-01